NCT03637413

Brief Summary

Research question: Does feeding hindmilk improve weight gain in very preterm infants with poor growth velocity? Hypothesis: In very preterm infants (born less than 32 weeks gestation) with poor postnatal growth velocity (\<15 g/kg/day), feeding hindmilk would improve average weight gain by at least 4 g/kg per day. Study design: This will be a prospective cohort study in very preterm infants admitted to the Neonatal Intensive Care Unit (NICU) at Foothills Medical Centre

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 20, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

January 22, 2019

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

November 7, 2022

Status Verified

November 1, 2022

Enrollment Period

3.9 years

First QC Date

August 14, 2018

Last Update Submit

November 4, 2022

Conditions

Keywords

preterm infantshindmilk

Outcome Measures

Primary Outcomes (1)

  • Average Weight Gain

    Difference in weight gain the week before hindmilk and the week after

    2 weeks

Secondary Outcomes (7)

  • Effect of feeding hindmilk on anthropometrics

    At 36 weeks post menstrual age and/or discharge (up to 13 weeks)

  • Effect of feeding hindmilk on body mass index

    At 36 weeks post menstrual age and/or discharge (up to 13 weeks)

  • Incidence of extra uterine growth restriction

    At 36 weeks post menstrual age and/or discharge (up to 13 weeks)

  • Incidence of bronchopulmonary dysplasia and retinopathy of prematurity

    At 36 weeks post menstrual age and/or discharge (up to 13 weeks)

  • Correlation between human milk content (fat, protein and energy) and weight gain

    Within 4 weeks of enrollment

  • +2 more secondary outcomes

Study Arms (1)

Hindmilk

EXPERIMENTAL

Hindmilk, the milk at the end of a breast pumping session, has higher fat and energy content compared to the composite milk.

Dietary Supplement: Hindmilk

Interventions

HindmilkDIETARY_SUPPLEMENT

Mother will be taught to separate her milk and infant will receive only hindmilk for feeds

Hindmilk

Eligibility Criteria

Age2 Weeks+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Very preterm infant ( \<32 weeks at birth)
  • On full enteral feeds for more than 2 weeks (full feed is defined at the time of reaching 120 ml/kg/day with no parenteral nutrition used)
  • Poor weight gain (\<15 g/kg per day) despite optimization of energy and protein intakes by RDs (calories intake: 125-135 Kcal/kg per day and protein: 4-4.5 g/kg per day)
  • Mothers have enough milk supply (\>150% of infant's daily needs)

You may not qualify if:

  • Congenital anomalies
  • Small for gestational age infants (\< 10th percentile) at birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foothills Medical Centre

Calgary, Alberta, T2N2T9, Canada

RECRUITING

MeSH Terms

Conditions

Weight Gain

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Belal Alshaikh, MD, MSc

    University of Calgary

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Belal Alshaikh, MD, MSc

CONTACT

Zainab Towage, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Neonatologist

Study Record Dates

First Submitted

August 14, 2018

First Posted

August 20, 2018

Study Start

January 22, 2019

Primary Completion

December 30, 2022

Study Completion

December 31, 2022

Last Updated

November 7, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations